Hippocampal Activated Microglia May Contribute to Blood-Brain Barrier Impairment and Cognitive Dysfunction in

Kun Ni1, Jixiang Zhu1, Xuan Xu1

  • 1Department of Anesthesiology, Drum Tower Hospital, Medical School of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.

Insights

Post-traumatic stress disorder (PTSD) impairs cognitive function early on due to blood-brain barrier (BBB) breakdown. Microglia activation contributes to this BBB damage and cognitive deficits in a rat model.

Area of Science:

  • Neuroscience
  • Pathology
  • Pharmacology

Background:

  • Post-traumatic stress disorder (PTSD) is linked to cognitive dysfunction, impacting quality of life.
  • The exact mechanisms behind PTSD-associated cognitive impairment remain unclear.
  • Emerging evidence suggests blood-brain barrier (BBB) dysfunction contributes to early cognitive deficits.

Purpose of the Study:

  • To investigate the role of microglia in BBB remodeling and cognitive dysfunction in an animal model of PTSD.
  • To explore the relationship between BBB integrity, microglial activation, and cognitive performance following single prolonged stress (SPS).

Main Methods:

  • Established a single prolonged stress (SPS) rat model to mimic PTSD.
  • Assessed cognitive function using the Y-maze test.
  • Evaluated BBB integrity via sodium fluorescein (NaFlu) assay and Western blotting for tight junction proteins (occludin, claudin 5).
  • Administered minocycline to inhibit microglial activation and assessed its effects.

Main Results:

  • SPS-induced rats showed impaired cognitive performance and increased BBB permeability (NaFlu passage) in the hippocampus.
  • Reduced expression of tight junction proteins (occludin, claudin 5) was observed in the hippocampus post-SPS.
  • Minocycline treatment attenuated cognitive deficits and mitigated BBB impairment, including reduced NaFlu extravasation and normalized tight junction protein levels.
  • These effects were most pronounced on the day after SPS, with less difference noted by the 7th day.

Conclusions:

  • Blood-brain barrier (BBB) impairment is implicated in the pathology of PTSD-associated cognitive dysfunction.
  • Microglial activation plays a significant role in BBB remodeling and exacerbating cognitive deficits during the early stages of SPS-induced PTSD.
  • Targeting microglial activation may offer a therapeutic strategy for mitigating cognitive impairments in PTSD.